S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|NICE Actimize Anti-Money Laundering Poll Finds Only 48 Percent of Financial Institution Respondents Believe They Have a Strong Culture of Compliance|
|Results from Phase III Study (AML-001) of VIDAZA® (Azacitidine for Injection) in Acute Myeloid Leukemia Presented at EHA|
|Karyopharm Initiates Registration-Directed, Randomized Study of Selinexor (KPT-330) in Older Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)|
|Stemline Therapeutics Announces Opening of SL-401 Corporate IND and Start of Clinical Trials in BPDCN and AML|
|Lorus Therapeutics Receives FDA Clearance of IND to Initiate LOR-253 Clinical Program in Patients with AML, MDS and other Blood Cancers|
|Kleangas Energy Technologies, Inc. Ships Another 100 Metric Tons (2014/9/4)|
|Celator(R) Pharmaceuticals Provides Update on CPX-351 and Technology Platform at Analyst Day|
|Agilent Technologies Introduces Next-Generation Sequencing Cancer Research Panels (2014/9/2)|
|MacroGenics Initiates Phase 1 Study of MGD006 for the Treatment of Acute Myeloid Leukemia|
|Panther Biotechnology, Inc. Announces a 6-1 Forward Stock Split to Increase Liquidity of Their Common Stock and Intent to List on the NYSE or NASDAQ (2014/9/8)|
Click above to view more mutual fund data and stats for aml - Argus Corporation Limited.